Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 10 of 13« First...89101112...Last »

Senator calls on Medtronic, FDA for bone graft injury data

U.S. Senator Al Franken asked federal regulators and Medtronic Inc for detailed information about injuries associated with the company’s bone graft Infuse following a newspaper report that Medtronic hid thousands of adverse events linked to the product. The Minneapolis Star Tribune reported on Sunday that Medtronic studied the outcomes of 3,600 patients who received Infuse […]

Read More »

OCHWW Launches the Ogilvy CommonHealth Marketing Cloud

Redefines data-driven marketing services for the life sciences industry; partnership with Medikly further expands the network’s insight-driven client offerings

Read More »

U.S. regulators aim to ban founder of blood-testing firm Theranos: WSJ

U.S. federal health regulators have proposed banning Theranos Inc founder Elizabeth Holmes from the blood-testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory, the Wall Street Journal reported on Wednesday. The Centers for Medicare and Medicaid (CMS) said in letter dated March 18 that […]

Read More »

Mental health care in emergencies ‘not an optional luxury’: experts

Even during a humanitarian crisis, treating mental illnesses is not an optional luxury, experts said before a World Bank/World Health Organization meeting on the issue in Washington.

Read More »

Sean Parker sets up $250 million cancer immunotherapy collaboration

A $250 million grant from Silicon Valley billionaire Sean Parker aims to speed development of more effective cancer treatments by fostering collaboration among leading researchers.

Read More »

China says 202 detained in vaccine scandal

A total of 202 people have been detained in connection with a scandal over an illegal black market vaccine ring, the Chinese government said on Wednesday, as it vowed to improve supervision of the market. The case, involving millions of illegal trades of vaccines through a black market drugs ring, has ignited public ire and […]

Read More »

Medivation Stock Up After Rumors It Rejected Sanofi Acquisition Bid

San Francisco-based Medivation has reportedly rejected a bid by Paris-based Sanofi.

Read More »

Valeant Stock Falls on Default Fears, U.S. Rep. Criticizes Company

Valeant’s shares fell after the company received a notice of default over failure to file its 10-k form.

Read More »

Congress sends Obama bill on Zika drug development

U.S. lawmakers on Tuesday approved a bill to provide financial incentives to companies developing treatments for the Zika virus, and the White House said President Barack Obama was expected to sign the legislation although it is insufficient to meet the challenge. The measure allows the Food and Drug Administration to include Zika drug developers in […]

Read More »

FDA panel votes against approving Clovis’s cancer drug on current data

An independent panel of experts advising the U.S. Food and Drug Administration recommended that Clovis Oncology Inc’s lung cancer drug not be approved based on existing trial data. The panel voted 12-1 against giving the drug an accelerated approval, and recommended the FDA wait for the results from an ongoing late-stage trial that compares the […]

Read More »

Medicare ‘hospital star rating’ may correspond to patient outcomes

The Centers for Medicare and Medicaid Services has been letting patients grade their hospital experiences, and those “patient experience scores” may give some insight into a hospital’s health outcomes, a new study suggests. Some people have been concerned that patient experience isn’t the most important factor to measure, said coauthor Dr. Ashish K. Jha of […]

Read More »

Lawsuit vs Pfizer over Celebrex, Bextra safety is revived

A federal appeals court revived a long-running lawsuit accusing Pfizer Inc. of misleading investors about the safety of the company’s Celebrex and Bextra pain-relieving drugs.

Read More »

Two Indian generics makers end battle to copy drugs amid patent debate

Indian drugmakers give up a battle to copy drugs developed by Bristol-Myers Squibb and AstraZeneca, blaming lack of government support for cheap generics and Big Pharma pressure.

Read More »

Bayer to consider selling animal health if unable to bulk up: CEO

Bayer might look into selling its animal health division if it continues to struggle to find takeover targets for the business, the German drugmaker’s incoming chief executive said.

Read More »

Fresh Off Its $1.2 Billion Deal, Gilead Has Cash to Go Shopping Again

April 12, 2016By Alex Keown, Breaking News Staff   PALO ALTO, Calif. – Expect Gilead Sciences (GILD) to be more aggressive in M&A activity following its $1.2 billion deal to snap up Cambridge, Mass.-based Nimbus Apollo, Inc. earlier this month. That’s the message from analysts at Kenra Investors, which has taken a long-term stake […]

Read More »

U.S. officials warn Zika ‘scarier’ than initially thought

Top health officials expressed heightened concern on Monday about the threat posed to the United States by the Zika virus, saying the mosquito that spreads it is now present in about 30 states and hundreds of thousands of infections could appear in Puerto Rico. At a White House briefing, they stepped up pressure on the […]

Read More »

Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 11, 2016 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Intellia Therapeutics, Inc. announced today a licensing and collaboration agreement to advance CRISPR/Cas gene-editing technology for in vivo therapeutic development. In addition to the discovery, development and commercialization of new therapies, the companies will focus on technology development of […]

Read More »

Short sleep may be tied to cold or infection risk

U.S. adults who sleep no more than five hours per night or who have a diagnosed sleep disorder are more likely to have suffered a recent cold than those who sleep more.

Read More »

Valeant asks CEO Pearson to cooperate with U.S. Senate committee

Valeant Pharmaceuticals International Inc. said it had asked outgoing CEO Michael Pearson to cooperate with the U.S. Senate Committee on Aging after he failed to show up at a hearing.

Read More »

Questionable Business Approach, Ethics Allegations for Verily CEO

Verily, formerly Google Life Sciences, is coming under fire for how its CEO approaches business, including some raised eyebrows over a research contract.

Read More »

Page 10 of 13« First...89101112...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom